David Adair is a co-founder and managing director at Solas BioVentures, focusing on medical device and therapeutic investments. He has nearly 20 years of experience as a physician and investor.
At firms with a similar stage, sector and check size.
One email when David's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckDavid Adair is a co-founder and managing director at Solas BioVentures, focusing on medical device and therapeutic investments. He has nearly 20 years of experience as a physician and investor.
Solas BioVentures has not reported a check size. It invests at seed.
A warm intro from a founder Solas BioVentures backed works best. A short LinkedIn note with one line on traction is the next best route.
Last updated 2026-10-15. Is this you? Ask for a correction.